Literature DB >> 20370708

Natural products: potential for developing Phellodendron amurense bark extract for prostate cancer management.

Addanki P Kumar1, Heather Graham, Craig Robson, Ian M Thompson, Rita Ghosh.   

Abstract

Our ability to detect and treat most primary cancers has improved dramatically given the advances in our understanding of cancer biology. However, with increased life expectancy and our inability to treat or cure advanced stages of cancers, the number of cancer-related deaths is expected to double in the next decade. Epidemiological studies suggest that dietary factors are an important aspect that influences cancer risk. Despite a lack of scientific evidence in most cases, cancer patients have whole-heartedly accepted the concept of "alternative medicine" using natural compounds and spent more than $1B a year on herbal supplements. Given the significant toxicity-associated problems with current long-term standard of care, scientifically validated natural supplements can serve as novel and effective alternative strategies for effective cancer management. We will discuss the utility of natural products in modulating critical signaling pathways for effective cancer prevention with special emphasis on prostate cancer and their potential translational benefit.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20370708     DOI: 10.2174/138955710791330936

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  6 in total

1.  Sensitivity and mechanisms of taxol-resistant prostate adenocarcinoma cells to Vernonia amygdalina extract.

Authors:  Keyuna S Cameron; Carolyn B Howard; Ernest B Izevbigie; Brandon J Hill; Paul B Tchounwou
Journal:  Exp Toxicol Pathol       Date:  2012-12-11

2.  Antiproliferative Effect of Phellodendron amurense Rupr. Based on Angiogenesis.

Authors:  Ľudmila Balážová; Slavomír Kurhajec; Martin Kello; Zdenka Bedlovičová; Martina Zigová; Eva Petrovová; Katarína Beňová; Ján Mojžiš; Jarmila Eftimová
Journal:  Life (Basel)       Date:  2022-05-21

3.  Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer.

Authors:  Jingjing Gong; Jianping Xie; Roble Bedolla; Paul Rivas; Divya Chakravarthy; James W Freeman; Robert Reddick; Scott Kopetz; Amanda Peterson; Huamin Wang; Susan M Fischer; Addanki P Kumar
Journal:  Clin Cancer Res       Date:  2014-02-11       Impact factor: 12.531

4.  Chemical Discrimination of Cortex Phellodendri amurensis and Cortex Phellodendri chinensis by Multivariate Analysis Approach.

Authors:  Hui Sun; Huiyu Wang; Aihua Zhang; Guangli Yan; Ying Han; Yuan Li; Xiuhong Wu; Xiangcai Meng; Xijun Wang
Journal:  Pharmacogn Mag       Date:  2016 Jan-Mar       Impact factor: 1.085

5.  Nexrutine® preserves muscle mass similar to exercise in prostate cancer mouse model.

Authors:  Darpan I Patel; Derek Wallace; Kira Abuchowski; Paul Rivas; Amber Gallegos; Nicolas Musi; Addanki Pratap Kumar
Journal:  Physiol Rep       Date:  2019-08

6.  Nexrutine and exercise similarly prevent high grade prostate tumors in transgenic mouse model.

Authors:  Darpan I Patel; Kira Abuchowski; Roble Bedolla; Paul Rivas; Nicolas Musi; Robert Reddick; A Pratap Kumar
Journal:  PLoS One       Date:  2019-12-19       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.